Stephanie Grancharov Ainscow

Stephanie Grancharov Ainscow has a diverse work experience spanning various industries. Currently, they are the Vice President and General Manager of Data Products at Insulet Corporation. In this role, they are responsible for overseeing the development and management of data products.

Previously, Stephanie served as a Board Member at Dallas Zoo from 2022 onwards. Stephanie also held multiple positions at Alcon, including Vice President of Surgical Solutions Incubation, Global Head of Digital Health, Diagnostics and Service, Global Head of Commercial Solutions, and Head of Strategy. In these roles, they managed strategic planning, led the implementation of digital health offerings, and developed business models to drive customer adoption of Alcon's procedural offerings.

Prior to their time at Alcon, Stephanie worked at McKinsey & Company as an Associate Partner, focusing on healthcare strategy for pharmaceutical and medical device companies. Stephanie also held a role as a Nanomaterials and Devices Researcher at IBM and served as a Fulbright Scholar at Fulbright Association.

Overall, Stephanie has demonstrated expertise in strategic planning, business development, and healthcare strategy across various organizations.

Stephanie Grancharov Ainscow earned their Bachelor of Science (BS) degree in Chemistry from the University of California, Berkeley in 1999. Stephanie then pursued further studies at Columbia University, where they obtained a Master of Science (M.S.) degree in Materials Science Engineering in 2001. Stephanie continued their education at Columbia University and received a Master of Philosophy (MPhil) degree in Materials Science Engineering in 2003. Finally, they completed their education at Columbia University by earning a PhD in Materials Science Engineering in 2005.